Main menu button

News

Equity Research ALM Equity, Q3 2026: Several development projects were started during the quarter
12 Oct 2026
Equity Research ALM Equity, Q3 2026: Several development projects were started during the quarter
Equity Research ALM Equity
Equity research CDON: Preview Q3 2026 - Fyndiq in focus
08 Oct 2026
Equity research CDON: Preview Q3 2026 - Fyndiq in focus
Equity Research CDON
Equity research Pila Pharma: XEN-D0501 returns to the clinic, with higher exposure now in focus
29 Sep 2026
Equity research Pila Pharma: XEN-D0501 returns to the clinic, with higher exposure now in focus
Equity Research Pila Pharma
Equity research, Immunovia: Announced rights issue and pause of coverage
29 Sep 2026
Equity research, Immunovia: Announced rights issue and pause of coverage
Equity Research Immunovia
Equity research, WPTG: Large AI infrastructure order boosts sales outlook
16 Sep 2026
Equity research, WPTG: Large AI infrastructure order boosts sales outlook
Equity Research White Pearl Technology Group
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
28 Aug 2026
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
Equity Research Pila Pharma
Equity research Zinzino Q2 2026: Strong profitability trend
26 Aug 2026
Equity research Zinzino Q2 2026: Strong profitability trend
Equity Research Zinzino
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
26 Aug 2026
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
Equity Research White Pearl Technology Group
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
25 Aug 2026
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
Equity Research Zinzino
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
21 Aug 2026
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
Equity Research Viva Wine Group
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
21 Aug 2026
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
Equity Research Angler Gaming
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
20 Aug 2026
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
Equity Research Angler Gaming
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
20 Aug 2026
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
Equity Research Viva Wine Group
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
18 Aug 2026
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
Equity Research Pila Pharma
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
11 Aug 2026
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
Equity Research Elicera Therapeutics
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
07 Aug 2026
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
Equity Research Immunovia
Equity Research ALM Equity, Q2 2026: Revenue is expected to increase during H2 2026
17 Jul 2026
Equity Research ALM Equity, Q2 2026: Revenue is expected to increase during H2 2026
Equity Research ALM Equity
Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
16 Jul 2026
Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
Equity Research ALM Equity
Equity research CDON, Q2 2026: GMV leads, profits should follow
16 Jul 2026
Equity research CDON, Q2 2026: GMV leads, profits should follow
Equity Research CDON
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
15 Jul 2026
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
Equity Research CDON